Overview

A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back Pain

Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the study was to characterize the safety, effectiveness, and impact on quality of life (QOL) measures of OROS® hydromorphone HCL in patients with chronic low back pain.
Phase:
Phase 2
Details
Lead Sponsor:
Alza Corporation, DE, USA
Treatments:
Hydromorphone